omniture

Asia Pharma R&D Leaders 2011 - The Largest and Premier Pharma R&D Summit in China

Global Leaders Institute
2010-11-29 18:56 1412

SHANGHAI, Nov. 29, 2010 /PRNewswire-Asia/ -- Drug discovery and research activities have traditionally focused on diseases common in the U.S. and Europe. That is, after all, where the money is. China is grabbing an increasing share of the global R&D budget, with investigators launching a slew of new studies to help understand how to treat the country's huge population and tap into one of the fastest growing pharma markets on the planet. As the premier pharma R&D conference in China, Asia Pharma R&D Leaders 2011 is organized under this background and supported by SAPA and SABPA. We welcome you to join this important meeting to meet the head of R&D centers from the top 20 of big pharma in China, leading China local pharma and biotech, global CROs and top pharma research institutes to explore R&D partnering, external research, licensing opportunities in China.

Featured Speakers:


Steve Q. Yang, Vice President, Head of Asia R&D, Pfizer


RuiPing Dong, MD&Ph.D. Vice President, Head of R&D Japan & China, Bristol-Myers Squibb


Gerd Maass, Global Head of Biomarker and Pathway Analysis, Roche Pharma Research and Early Development


Peter Hongaard Anderson, Executive Vice President, Head of Research, H. Lundbeck A/S


Samantha Du, President, Hutchison Medipharm


Davinder Gill, PhD VP/Head Global Biotherapeutics Technologies, Pfizer


Xiaolin Zhang, Vice President and the Head of the Innovation Center China (ICC), AstraZeneca


Xin Ma, Head of Global Drug Discovery - Innovation Center China, Bayer Schering Pharma


and more from top 20 big pharma and Chinese big pharma and biotech companies





For more registration and sponsorship enquiry, please contact Daniel Chen of Global Leaders Institute at daniel.chen@globaleaders.com or 8621-32516046.

About Global Leaders Institute

Global Leaders Institute (GLI) is the producer and organizer of top-level business events. We focus on the development and operation of the strategic, market leading business conference. We focus on the specialty spirit and professional attainment. We focus on value creation for our client. We provide 60 annual conferences across energy, finance, transportation, life science, real estate, telecom and media, etc. each year.



Source: Global Leaders Institute
collection